Prosecution Insights
Last updated: November 04, 2026

New York Genome Center Inc.

Technology area: Biotechnology & Pharmaceuticals

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

New York Genome Center Inc. has 1 pending office action in Biotechnology & Pharmaceuticals. The matter is handled by 1 distinct examiner in 1 distinct art unit.

FONSECA LOPEZ, FRANCINI ALVARENGA is the busiest examiner, with 1 pending office action. The focused record supports direct attention to the examiner’s issues and the next response.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
1
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (100%)
0
Medium (0%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
FONSECA LOPEZ, FRANCINI ALVARENGA 1 26.7% +31.8%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18682736 ULTRA-SENSITIVE LIQUID BIOPSY THROUGH DEEP LEARNING EMPOWERED WHOLE GENOME SEQUENCING OF PLASMA FONSECA LOPEZ, FRANCINI ALVARENGA —

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18682736 ULTRA-SENSITIVE LIQUID BIOPSY THROUGH DEEP LEARNING EMPOWERED WHOLE GENOME SEQUENCING OF PLASMA FONSECA LOPEZ, FRANCINI ALVARENGA —

Top Art Units

Art UnitApps
1685 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18682736 ULTRA-SENSITIVE LIQUID BIOPSY THROUGH DEEP LEARNING EMPOWERED WHOLE GENOME SEQUENCING OF PLASMA FONSECA LOPEZ, FRANCINI ALVARENGA 1685 §101§103 Non-Final OA — Pending Feb 09, 2024

Managing New York Genome Center Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does New York Genome Center Inc. have?

New York Genome Center Inc. has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.

Which USPTO examiner handles the most New York Genome Center Inc. applications?

Francini Alvarenga Fonseca Lopez has the most, with 1 of New York Genome Center Inc.'s pending office actions.

What technology area are New York Genome Center Inc.'s patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month